CrushSCI.com
94.8平均天数
98.5中位天数
38最短天数
194最长天数
2322025发文量

Paper Review Records

全部论文审稿周期

20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

103 天

Global trends in metabolic-associated hepatocellular carcinoma: genetic and socio-demographic drivers

作者
Na Wu; Xinying Xiong; Xinyue Wang; Shuang Wei; Xinyu Shi; Yilin Chen; Wenjun Zhou; Jianying Wang; Lei Zhang; Baocheng Liu; Hualing Song; Huiting Yu; Guang Ji展开收起
作者单位
1. School of Public Health, Shanghai Innovation Center of Traditional Chinese Medicine Health Service, Shanghai University of Traditional Chinese Medicine, Shanghai, China; 2. State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China; 3. Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China; 4. Shanghai Municipal Center for Disease Control and Prevention, Shanghai Academy of Preventive Medicine, Shanghai, China展开收起
PDF源文件 DOI 网页
99 天

Obstructive sleep apnea mediates the association between body mass index and metabolic dysfunction-associated steatotic liver disease in patients with obesity

作者
Peikai Zhao; Juanjuan Zou; Yuxuan Li; Shaozhuang Liu; Ze-Hua Zhao; Xin Huang展开收起
作者单位
1. Division of Bariatric and Metabolic Surgery, Department of General Surgery, Qilu Hospital of Shandong University, Jinan, China; 2. Department of Otorhinolaryngology, NHC Key Laboratory of Otorhinolaryngology (Shandong University), Qilu Hospital of Shandong University, Jinan, China; 3. Department of Hepatology, Qilu Hospital of Shandong University, Jinan, China展开收起
PDF源文件 DOI 网页
110 天

Methodological Considerations in the MAFLD-MASLD Dichotomy for Cardiac Risk Assessment

作者
Ruihang Luo; Maosen Liu; Jianbo Wu; Xuyang Liu; Zhehao Wu; Jingtao Zhang; Mingshan Liu展开收起
作者单位
1. Department of Thoracic Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People’s Republic of China; 2. Jiangxi Medical College, The First Clinical Medical College of Nanchang University, Nanchang University, Nanchang, People’s Republic of China; 3. Jiangxi Medical College, HuanKui College of Nanchang University, Nanchang University, Nanchang, People’s Republic of China; 4. Jiangxi Hospital of China-Japan Friendship Hospital, National Regional Center for Respiratory Medicine Nanchang, Nanchang, People’s Republic of China; 5. Jiangxi Institute of Respiratory Disease, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People’s Republic of China展开收起
PDF源文件 DOI 网页
143 天

The Asian Pacific Association of the Study of the Liver expert survey on artificial intelligence-assisted reporting of liver histopathology in metabolic dysfunction associated fatty liver disease

作者
H. Elangovan; K. Akbary; A. Rastogi; A. Wee; G. Soon; L. Adams; E. Carr-Boyd; A. Clouston; C. L. Cooper; W. K. Chan; Y. Y. Dan; R. Dela-Cruz; G. Goh; S. S. Hamid; D. Q. Huang; T. Kawaguchi; H. Kim; W. Kim; S. U. Kim; J. D. Jia; C. J. Liu; F. Liu; W. Q. Leow; M. D. Muthiah; I. Ng; D. Payawal; A. F. Pan; S. Pervez; G. Shiha; T. Tanwandee; Y. Tanaka; L. Thiyaphat; M. Vij; Y. Yilmaz; F. Yilmaz; M. L. Yu; K. Zalata; M. H. Zheng; J. G. Fan; S. K. Sarin; V. Wong; J. George展开收起
作者单位
1. Storr Liver Centre, The Westmead Institute for Medical Research, Westmead Hospital, The University of Sydney, Sydney, Australia; 2. HistoIndex Pte Ltd, Singapore, Singapore; 3. Department of Pathology, Institute of Liver and Biliary Sciences, New Delhi, India; 4. Department of Pathology, National University Hospital, Singapore, Singapore; 5. Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore; 6. Medical School, University of Western Australia, Perth, Washington, Australia; 7. Histopathology Department, Auckland City Hospital, Auckland, New Zealand; 8. Centre for Liver Disease Research, School of Medicine (Southern), University of Queensland, Princess Alexandra Hospital, Ipswich, Australia; 9. Pathology Queensland, Princess Alexandra Hospital, Woolloongabba, Australia; 10. Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; 11. Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore; 12. The Medical City, Ortigas, Pasig City, Metro Manila, Philippines; 13. Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore, Singapore; 14. Department of Medicine, Aga Khan University, Karachi, Pakistan; 15. Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan; 16. Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea; 17. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul National University College of Medicine, Seoul, Republic of Korea; 18. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea; 19. Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China; 20. Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; 21. Peking University People’s Hospital, Peking University Hepatology Institute, Infectious Disease and Hepatology Center, Peking University People’s Hospital, Beijing, China; 22. Department of Pathology and State Key Laboratory of Liver Research, The University of Hong Kong, Pok Fu Lam, Hong Kong; 23. Department of Internal Medicine, Fatima University Medical Center, Valenzuela, Philippines; 24. Department of Pathology, Queen Elizabeth Hospital, Sabah, Malaysia; 25. Department of Pathology, Aga Khan University, Karachi, Pakistan; 26. Gastroenterology and Hepatology Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt; 27. Division of Gastroenterology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Bangkok, Thailand; 28. Department of Gastroenterology and Hepatology, Kumamoto University, Kumamoto, Japan; 29. Division of Pathology, Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, Thailand; 30. Department of Pathology, Dr Rela Institute and Medical Center, Chennai, India; 31. Department of Gastroenterology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Türkiye; 32. Faculty of Medicine, Department of Pathology, Ege University, Izmir, Türkiye; 33. Hepatobiliary Division, Department of Internal Medicine, Center of Hepatitis Research, College of Medicine and Center of Metabolic Disorders and Obesity, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; 34. Anatomic Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt; 35. Department of Hepatology, MAFLD Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; 36. Center for Fatty Liver, Department of Gastroenterology, Shanghai Key Lab of Pediatric Gastroenterology and Nutrition, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; 37. Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India; 38. Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, Hong Kong展开收起
PDF源文件 DOI 网页
158 天

New therapies for primary biliary cholangitis

作者
Aalam Sohal; Mariam Alamgir; Kris V. Kowdley展开收起
作者单位
1. Liver Institute Northwest, Seattle, USA; 2. Creighton University, Phoenix, USA; 3. Elson S. Floyd College of Medicine, Washington State University, Spokane, USA展开收起
PDF源文件 DOI 网页
56 天

Is triple therapy redefining first-line treatment in intermediate-advanced hepatocellular carcinoma?

作者
Shuntaro Obi; Masao Omata展开收起
作者单位
1. Department of Internal Medicine, Teikyo University Chiba Medical Center, Ichihara, Japan; 2. Department of Gastroenterology, Yamanashi Prefectural Central Hospital, Yamanashi, Japan; 3. The University of Tokyo, Tokyo, Japan展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿62 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 [email protected]

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。